Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenocarcinoma
Scientists at Food & Drug Administration report research in pharmaceuticals
June 9th, 2009
"Work in the field ''omics'' (toxicogenomics, proteomics, and metabolomics) has exploded. It is hoped that 'omics' could be a tool for evaluation of general toxicology, reproductive toxicology, the carcinogenicity potential of pharmaceuticals and several other types of toxicity, eventually replacing the use of animals," scientists in the United States report. "Although much progress has been made in the standardization of procedures, challenges remain for evaluation of pharmaceuticals for regulatory Purposes, because Of off-target toxicologic effects, as well as issues of interpretation and the large number of biologic variables that can affect results. Such variables...
Source: Cancer Weekly (2009-06-09)
|
